Monday, November 23, 2009, 9:03pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Stereotaxis Inc. (STXS)

 At 15:59 EST: 3.95 USD  Up 0.12 (3.13%)  
MORE ON STXS
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Stereotaxis, Inc. (NGM:STXS) Delayed quote dataEdit
After Hours: 3.98 Up 0.03 (0.72%) as of 4:15pm EST on 11/23/09
Last Trade: 3.95 USD
Trade Time: 3:59PM EST
Change: Up 0.12 (3.13%)
Prev Close: 3.83
Open: 3.92
Bid: 3.80 x 1000
Ask: 4.48 x 100
1y Target Est: 12.75
Day's Range: 3.90 - 4.08
52wk Range: 2.30 - 5.19
Volume: 394,429
Avg Vol (3m): 321,112
Market Cap: 198.52M
P/E (ttm): N/A
EPS (ttm): -1.20
Div & Yield: N/A (N/A%)
Stereotaxis Inc. (STXS)
1d  5d  3m  6m  1y  2y  5y  max 
 Add STXS to Portfolio   Download Data

HEADLINES
• [$$] Two Cheap Stocks, and a Look Ahead
at RealMoney by TheStreet.com (Mon 1:33pm)
• Farrell: Obama Hectored, Ignored and Restricted?
at CNBC (Mon 8:51am)
• STEREOTAXIS, INC. Financials
EDGAR Online Financials (Fri, Nov 13)
• Hansen Medical: A Stock to Make Any Investor's Heart Happy
at Seeking Alpha (Thu, Nov 12)
• New Star Analyst Rankings for Stereotaxis, Inc.
StarMine (Sun, Nov 8)
• STEREOTAXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Fri, Nov 6)
• Q3 2009 Stereotaxis Inc. Earnings Release - Before Market Open
CCBN (Thu, Nov 5)
• Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth Revenue of $13.3 Million; Recurring Revenue Grows 45%; Gross Margin Increases to 68% of
PRNewswire (Thu, Nov 5)
• Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
PRNewswire (Fri, Oct 30)
• Stereotaxis Announces Third Quarter 2009 Earnings Release Date and Conference Call
PRNewswire (Thu, Oct 22)
• STEREOTAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Tue, Oct 13)
• Stereotaxis: Underwriters buy 975,000 more shares
AP (Mon, Oct 12)
More Headlines for STXS...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 2.7
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Stereotaxis, Inc. engages in the design, manufacture, and marketing of cardiology instrument control system for the interventional treatment of coronary artery disease and arrhythmias in the United States, Europe, and internationally.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices